Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesEstrogen receptor-dependent attenuation of hypoxia-induced changes in the lung genome of pulmonary hypertension rats.Gremlin1 plays a key role in kidney development and renal fibrosisBone morphogenetic proteins and their antagonists: current and emerging clinical uses.Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension.Bone morphogenetic protein signalling in pulmonary hypertension: advances and therapeutic implications.Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.Reply to "Bone morphogenetic protein's contribution to pulmonary artery hypertension".BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration.Gremlin and renal diseases: ready to jump the fence to clinical utility?Emerging Therapeutics in Pulmonary Hypertension.Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension.REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature.
P2860
Q26739015-96CF367B-0C28-454D-8E1D-F6D0B4724961Q33738546-BD88B07B-BD1D-4958-BADD-195830B2BACCQ33867359-C6F90B84-6CB3-4645-BCC4-6A0F072DB087Q34025148-AD19597A-8826-4B55-81ED-1E76F0A68A70Q36352101-9B60A7B7-A95C-4A85-B4CE-D5BC21402FE6Q37555347-0409FB2D-DD9B-4E60-B2C4-919891B3BE99Q38690162-91861193-0678-4E13-90CB-AF363E3670B3Q38942069-DD786F5D-DE9C-48D0-903C-C912BC94B694Q39760107-CE477257-255A-4910-9EA3-5CA77DEC84E9Q41660197-5FA44888-E1CD-4102-9116-A173D9794682Q47237512-BCC57BF3-6690-46FA-9754-BD4E77FC3FE8Q47676484-56B6003D-0C5D-481E-992F-205B46AA04F4Q47700134-0BCA62DF-D440-4D88-825E-EF42FA4DA42DQ48201616-C7598363-0BA2-4483-8322-E5D25F1F3159Q49562927-0B1FB015-EA4D-4DEF-BD0A-B0870D184C4C
P2860
Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Treatment with anti-gremlin 1 ...... arterial hypertension in mice.
@en
Treatment with anti-gremlin 1 ...... arterial hypertension in mice.
@nl
type
label
Treatment with anti-gremlin 1 ...... arterial hypertension in mice.
@en
Treatment with anti-gremlin 1 ...... arterial hypertension in mice.
@nl
prefLabel
Treatment with anti-gremlin 1 ...... arterial hypertension in mice.
@en
Treatment with anti-gremlin 1 ...... arterial hypertension in mice.
@nl
P2093
P2860
P1476
Treatment with anti-gremlin 1 ...... arterial hypertension in mice.
@en
P2093
Daniel Sutton
Gabor Jarai
Gerald Dubois
Gino Van Heeke
Jenny Simmons
Karen England
Kellyann Sheppard
Liqun Dong
Loredana Ciuclan
Martin Hussey
P2860
P304
P356
10.1016/J.AJPATH.2013.07.017
P407
P577
2013-11-01T00:00:00Z